Shandong Polymer Biochemicals Co., Ltd.

Sümbol: 002476.SZ

SHZ

4.61

CNY

Turuhind täna

-1078.4464
P/E suhe
12.5889
PEG suhe
2.82B
MRK Cap
0.00%
DIV tootlus

Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 563.416 M, mis on 0.057 % gowth. Kogu perioodi keskmine brutokasum on 97.591 M, mis on 0.121 %. Keskmine brutokasumi suhtarv on 0.171 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 0.651 %, mis on võrdne -3.019 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Shandong Polymer Biochemicals Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.048. Käibevara valdkonnas on 002476.SZ aruandlusvaluutas 761.747. Märkimisväärne osa neist varadest, täpsemalt 305.577, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.238%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 79.457, kui neid on, aruandlusvaluutas. See näitab erinevust 839.498% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 0 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 6.137%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 869.606 aruandlusvaluutas. Selle aspekti aastane muutus on 0.035%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 365.121, varude hind on 84.46 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 10.18.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
balance-sheet.row.cash-and-short-term-investments	1259.11	305.6	401	361.8	415.1	442.3	417.8	132.9	91.1	205.6	173.6	285.2	320.7	453	42.4	46.3	14.9
balance-sheet.row.short-term-investments	0.31	0.3	0	-18.6	-0.7	-1.1	-1.5	-1.4	-0.7	-1.6	-0.6	0	0	0	0	0	0
balance-sheet.row.net-receivables	1010.97	365.1	248.1	127.9	42.3	74.9	178.6	366.1	500.7	512.3	244.4	211.3	240.9	179	92.6	76.9	59.3
balance-sheet.row.inventory	426.51	84.5	82	65.7	91.2	91.6	44.9	65.3	104.9	65.5	90.5	98.3	107.8	74.5	33.1	56	124.1
balance-sheet.row.other-current-assets	15.57	6.6	24.1	13.5	16.2	15.5	52.2	71.3	45.2	52.6	168.5	43.5	16	-2.1	-1.8	-2.4	-5.3
balance-sheet.row.total-current-assets	2712.15	761.7	755.1	568.9	564.9	624.3	693.5	635.6	741.9	836	677	638.3	685.4	704.4	166.3	176.8	192.9
balance-sheet.row.property-plant-equipment-net	745.39	182.4	200.8	390	240.2	347.3	477.3	689.2	658.4	409.8	348	342.5	281.8	198.2	201	182.8	157.7
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	21	21	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	441.88	10.2	10.7	11.3	12	37.2	39.6	41.2	24.2	22.2	16.4	18.1	19.8	18.1	14.4	15.4	1.2
balance-sheet.row.goodwill-and-intangible-assets	441.88	10.2	10.7	11.3	12	37.2	39.6	41.2	45.3	43.3	16.4	18.1	19.8	18.1	14.4	15.4	1.2
balance-sheet.row.long-term-investments	278.39	79.5	8.5	31.5	15.3	18	27	42.4	45.6	49.3	49.6	0	0	0	0	0	0
balance-sheet.row.tax-assets	20.63	5.8	6.5	7.1	10.9	12	2.7	4.4	2.2	1.8	2.3	1.5	1.6	1.4	1.4	1.1	0.5
balance-sheet.row.other-non-current-assets	24.19	0.4	10.8	1.2	122.1	14.1	35.7	37.1	54.5	25.6	25.6	52.7	0.2	0.3	0	1	0
balance-sheet.row.total-non-current-assets	1510.49	278.2	237.3	441.1	400.4	428.5	582.2	814.3	805.9	529.8	441.8	414.7	303.4	218	216.9	200.3	159.4
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	4222.64	1040	992.4	1010.1	965.3	1052.8	1275.7	1449.9	1547.9	1365.8	1118.8	1053	988.8	922.4	383.1	377.1	352.3
balance-sheet.row.account-payables	262.9	134.6	63.1	58.5	85	98.8	99.9	157	210.2	118.9	86.4	61.1	59	46.8	68.8	51.3	90.3
balance-sheet.row.short-term-debt	60.91	11.4	1.4	43.1	58.1	30	33.5	54.5	82	60.2	0	0	0	0	80	152.4	100
balance-sheet.row.tax-payables	14.29	3.2	3.9	2.1	0.8	2.8	11.4	20.7	9	14.6	5.3	4.2	-3.4	5.7	5.8	2.5	16.6
balance-sheet.row.long-term-debt-total	0	0	0.1	77.9	8	38	64	42.7	0	0	0	0	0	0	40	0	0
Deferred Revenue Non Current	4.77	1.3	1.5	1.7	2	14.4	14.6	0.9	0.9	0.9	1.2	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	40.68	22.8	12	0.5	0.6	30	0.9	0.7	0.2	13.5	28.3	16.2	4.1	12.8	0.7	0.2	11.1
balance-sheet.row.total-non-current-liabilities	5.11	1.3	1.7	79.6	10	173	78.6	178.5	130.3	3.3	1.2	1.8	0	0	40	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2.3	1.4	0.1	77.9	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	497.51	170.4	152.4	188	156.5	334.6	287.3	414.3	447.2	230.1	116	79.1	63.1	59.6	199.2	210.8	220.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2448	612	612	612	612	612	612	612	612	612	612	360	180	120	90	90	90
balance-sheet.row.retained-earnings	108.28	29.1	-0.5	-18.5	-31.7	-120.5	149.7	159.8	169.3	169.7	144.9	192.9	156	100.5	76.4	63	31.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	568.62	53.5	53.5	53.5	53.5	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	349.96	175	175	175	175	226.6	226.6	216.2	234.6	236.4	240	415	589.7	642.3	17.6	13.3	9.8
balance-sheet.row.total-stockholders-equity	3474.86	869.6	840	822	808.8	718.1	988.4	988	1015.9	1018.1	996.9	967.9	925.7	862.8	184	166.3	131.6
balance-sheet.row.total-liabilities-and-stockholders-equity	4222.64	1040	992.4	1010.1	965.3	1052.8	1275.7	1449.9	1547.9	1365.8	1118.8	1053	988.8	922.4	383.1	377.1	352.3
balance-sheet.row.minority-interest	250.28	0	0	0	0	0	0	47.6	84.8	117.7	6	5.9	0	0	0	0	0
balance-sheet.row.total-equity	3725.13	869.6	840	822	808.8	718.1	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	4222.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	278.39	79.5	8.5	12.9	14.5	16.9	25.5	41.1	44.9	47.8	49	52.6	0	0	0	0	0
balance-sheet.row.total-debt	60.91	11.4	1.6	43.1	66.1	68	97.5	97.2	82	60.2	0	0	0	0	120	152.4	100
balance-sheet.row.net-debt	-1198.2	-294.2	-399.4	-318.8	-349	-374.3	-320.3	-35.7	-9.1	-145.4	-173.6	-285.2	-320.7	-453	77.6	106.2	85.1

Rahavoogude aruanne

Shandong Polymer Biochemicals Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -0.724 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 10.34 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -86706693.150. See on -1.726 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 34.89, 0.89, -9.94, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -0.41 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 17.67, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
cash-flows.row.net-income	-2.07	29.6	17.9	13.2	91.2	-264.1	0.4	-5.4	-9.9	48.3	47	51.2	67.8	56.8	42.8	34.7	25.8
cash-flows.row.depreciation-and-amortization	9.59	34.9	38.8	40.6	44.7	50.7	40.9	64.2	44.1	41.8	36.1	32.9	23.6	31.1	27.2	26.7	24.9
cash-flows.row.deferred-income-tax	0.69	0.7	-0.2	3.9	1.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-0.7	0.2	-3.9	-1.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-164.92	-153.9	-101.8	-33.6	21.8	15.3	103.3	52.3	34	-191.8	-16.2	85.9	-106.1	-146.9	-1.9	-57.7	-43.2
cash-flows.row.account-receivables	-161.99	-162	-206.5	-52.2	27.5	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-2.92	-2.9	-15.9	25.2	0.3	-46.7	20.3	39.7	-37.6	23.2	7.7	9.5	-33.3	-41.5	22.9	68.1	-29.6
cash-flows.row.account-payables	0	10.3	120.9	-10.5	-7.2	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	0.7	-0.2	3.9	1.1	62	83	12.6	71.6	-215	-23.9	76.4	-72.9	-105.5	-24.9	-125.8	-13.6
cash-flows.row.other-non-cash-items	108.17	11.2	10.2	12.3	-107.2	250.9	-56.7	34.1	54	-4.7	5	-0.2	5.2	7	13.7	13.5	11.4
cash-flows.row.net-cash-provided-by-operating-activities	104.27	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-11.7	-15	-19.2	-17.7	-10.4	-31.6	-86.7	-116.9	-219.2	-49.3	-45	-122.4	-94.4	-33.9	-28	-42.6	-48.5
cash-flows.row.acquisitions-net	-71.17	5.5	117.5	2.4	86.9	0	289.9	45.3	0	-39.9	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-40	-80	0.3	0	0	-10	-30	-38.9	0	0	0	-53.4	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	1.9	1.9	22.6	0	0	0.5	1.4	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-65.64	0.9	-1.7	24.1	-143.7	34.7	53.3	-20.2	-26.8	121.8	-120.5	-26.7	-15.8	0.3	0.1	0	0
cash-flows.row.net-cash-used-for-investing-activites	-117.35	-86.7	119.5	8.8	-67.2	-6.4	227.9	-130.7	-245.9	32.6	-165.6	-202.4	-110.2	-33.7	-27.9	-42.6	-48.5
cash-flows.row.debt-repayment	-21.82	-9.9	-30.3	-67	-30	-29.5	-47.5	-148.7	-95.2	-67.5	0	0	-50	-264.8	-199.8	-120	-112.8
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-0.57	-0.4	-5.7	-10.4	-4.6	-11.2	-19.8	-25	-22.6	-20	-18	-8.9	-12.6	-34	-10.4	-10.6	-8.1
cash-flows.row.other-financing-activites	24.81	17.7	-12	7	28	0	47.8	197	121.2	200.6	0	6	50	795	167.3	172.4	129.4
cash-flows.row.net-cash-used-provided-by-financing-activities	4.15	7.3	-48	-70.5	-6.6	-40.7	-19.4	23.4	3.5	113.1	-18	-2.9	-12.6	496.2	-42.9	41.9	8.6
cash-flows.row.effect-of-forex-changes-on-cash	0.91	0	0	0	0	0	0.1	-2.8	-8.9	-7.2	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-8.02	-157.6	36.6	-29.1	-23.2	5.7	296.6	35	-129.2	32.1	-111.6	-35.5	-132.3	410.6	11	16.6	-21.1
cash-flows.row.cash-at-end-of-period	1184.3	240.6	398.2	361.5	390.7	413.8	408.1	111.5	76.5	205.6	173.6	285.2	320.7	453	42.4	31.4	14.9
cash-flows.row.cash-at-beginning-of-period	1192.32	398.2	361.5	390.7	413.8	408.1	111.5	76.5	205.6	173.6	285.2	320.7	453	42.4	31.4	14.9	35.9
cash-flows.row.operating-cash-flow	104.27	-78.2	-34.8	32.5	50.6	52.7	87.9	145.1	122.2	-106.4	71.9	169.8	-9.5	-52	81.8	17.3	18.9
cash-flows.row.capital-expenditure	-11.7	-15	-19.2	-17.7	-10.4	-31.6	-86.7	-116.9	-219.2	-49.3	-45	-122.4	-94.4	-33.9	-28	-42.6	-48.5
cash-flows.row.free-cash-flow	92.56	-93.2	-54	14.9	40.2	21.1	1.2	28.2	-97	-155.7	26.9	47.5	-103.9	-85.9	53.8	-25.3	-29.7

Kasumiaruande rida

Shandong Polymer Biochemicals Co., Ltd. tulud muutusid võrreldes eelmise perioodiga -0.099%. 002476.SZ brutokasum on teatatud 129.6. Ettevõtte tegevuskulud on 100.83, mille muutus võrreldes eelmise aastaga on 31.224%. Kulud amortisatsioonikulud on 34.89, mis on -0.050% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 100.83, mis näitab 31.224% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.216% kasvu võrreldes eelmise aastaga. Tegevustulu on 30.73, mis näitab 0.216% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 0.651%. Eelmise aasta puhaskasum oli 29.63.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
income-statement-row.row.total-revenue	479.79	592.3	657.2	447.3	416.9	449.9	409.8	898	741.6	667.6	685	581.2	542.9	515.4	419.5	542.8	447.4
income-statement-row.row.cost-of-revenue	384.21	462.7	557.1	363.6	365.1	398.9	353.7	725.1	611.7	539.3	568.9	493.5	436	410.2	327.3	457.3	382.7
income-statement-row.row.gross-profit	95.58	129.6	100.1	83.7	51.8	51	56.1	172.9	130	128.3	116.1	87.7	106.8	105.2	92.1	85.5	64.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	18.04	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	11.99	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	26.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	39.57	41.2	28.9	19.7	27.2	-121.4	3.5	7.2	23.7	0.7	1.2	2.1	0.8	3.3	1.7	10.9	8.2
income-statement-row.row.operating-expenses	98.38	100.8	76.8	58.2	74.7	77.3	115.8	149.8	101.8	76.1	58.8	36.6	30.1	27.6	23.9	25.6	13.9
income-statement-row.row.cost-and-expenses	482.59	563.5	633.9	421.9	439.8	476.2	469.5	874.9	713.5	615.5	627.7	530.1	466.1	437.9	351.2	482.9	396.6
income-statement-row.row.interest-income	6.13	6.7	5.4	5.6	7.9	4.4	1.5	0.6	0.4	1.8	3	6.8	7.8	2.2	0.2	0.2	0.1
income-statement-row.row.interest-expense	0.58	0.5	4.7	9.7	4.6	5	1.4	5.2	4.2	1.7	0	0	0.6	6.9	9.8	10.6	8.4
income-statement-row.row.selling-and-marketing-expenses	26.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	2.98	0.3	-7.6	-9.8	-10.4	-247.1	61.8	-17.1	-24.7	7.8	-0.9	9.6	3.3	-1.7	-10.8	-13.4	-11.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	39.57	41.2	28.9	19.7	27.2	-121.4	3.5	7.2	23.7	0.7	1.2	2.1	0.8	3.3	1.7	10.9	8.2
income-statement-row.row.total-operating-expenses	2.98	0.3	-7.6	-9.8	-10.4	-247.1	61.8	-17.1	-24.7	7.8	-0.9	9.6	3.3	-1.7	-10.8	-13.4	-11.5
income-statement-row.row.interest-expense	0.58	0.5	4.7	9.7	4.6	5	1.4	5.2	4.2	1.7	0	0	0.6	6.9	9.8	10.6	8.4
income-statement-row.row.depreciation-and-amortization	-4.07	36.9	38.8	40.6	44.7	50.7	40.9	64.2	44.1	41.8	36.1	32.9	23.6	31.1	27.2	26.7	24.9
income-statement-row.row.ebitda-caps	-4.59	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-0.52	30.7	25.3	26.8	102.8	-152	-1.3	-1.1	-20.3	59.2	55.2	58.7	79.2	72.5	57.5	46.7	41.2
income-statement-row.row.income-before-tax	-2.13	31.1	17.7	17.1	92.4	-273.4	2.1	6	3.4	59.9	56.3	60.8	80.1	75.8	57.5	46.5	39.3
income-statement-row.row.income-tax-expense	-0.07	1.4	-0.2	3.9	1.1	-9.3	1.7	11.4	13.3	11.6	9.4	9.6	12.3	19	14.6	11.8	13.5
income-statement-row.row.net-income	-2.07	29.6	17.9	13.2	91.2	-264.1	8.3	14.8	24.1	47.9	46.9	51.2	67.8	56.8	42.8	34.7	25.8